Ozempic Cuts Risk of Kidney Disease Death in People with Diabetes
Semaglutide, the same compound in obesity drug Wegovy, slashes risk of kidney failure and death for people with type 2 diabetes
Ozempic Cuts Risk of Kidney Disease Death in People with Diabetes
Semaglutide, the same compound in obesity drug Wegovy, slashes risk of kidney failure and death for people with type 2 diabetes
Could Putting Neosporin in Your Nose Fend Off COVID?
People may someday have a surprisingly familiar tool to prevent viral infections: one of the antibiotics found in a common ointment
How Some Common Medications Can Make People More Vulnerable to Heat
As climate change brings more intense heat waves, scientists are trying to understand how certain medications interact with the body’s thermoregulation system
What Happens When You Quit Ozempic or Wegovy?
Many researchers think that Wegovy and Ozempic should be taken for life, but myriad factors can force people off the drugs
Paxlovid COVID Treatment Is Most Beneficial for Unvaccinated People with Risk Factors. Others May Not Need It
A recent study suggests that Paxlovid is ineffective at treating symptoms in people with mild illness or those who have been fully vaccinated. It is still a lifesaving medication in vulnerable groups
Does Long-Term Benadryl Use Increase Dementia Risk?
Benadryl, which contains diphenhydramine, is a drugstore mainstay and just one medication out of many that could possibly damage brain health
First Weight-Loss Drug Gets Approval for Heart Disease. Here’s What We Know
The FDA recently approved semaglutide (Wegovy) for preventing serious heart conditions in some people, but questions remain about how it works
People with Food Allergies Can Treat Symptoms with Asthma Medication, FDA Decides
New research demonstrates that Xolair, an injectable asthma medication, can reduce severe reactions to peanuts, milk and eggs by dulling an overactive immune response
These Cancers Were Beyond Treatment—But Might Not Be Anymore
New drugs called antibody-drug conjugates help patients with cancers that used to be beyond treatment
Ozempic and Mounjaro Aren’t the Same. Here’s How Weight-Loss Drugs Compare
A plethora of new weight-loss drugs are now available in the U.S., but they aren’t necessarily the same. Here’s a guide to the latest GLP-1 receptor agonists
AI Program Finds Thousands of Possible Psychedelics. Will They Lead to New Drugs?
Researchers have doubted how useful AI protein-structure tool AlphaFold will be in discovering medicines—now they are learning how to deploy it effectively
Lower Drug Costs Are Just a Federal License Away. But They Require Biden Administration Leadership
It’s a longstanding government failure to never use federal “march-in” licensing rights to lower drug prices. It’s also a mistake to limit them to only a few cases